Abstract
Lysine 63-linked polyubiquitin (K63-Ub) chains activate a range of cellular immune and inflammatory signaling pathways, including the mammalian antiviral response. Interferon and antiviral genes are triggered by TRAF family ubiquitin ligases that form K63-Ub chains. LGP2 is a feedback inhibitor of TRAF-mediated K63-Ub that can interfere with diverse immune signaling pathways. Our results demonstrate that LGP2 inhibits K63-Ub by association with and sequestration of the K63-Ub-conjugating enzyme, Ubc13/UBE2N. The LGP2 helicase subdomain, Hel2i, mediates protein interaction that engages and inhibits Ubc13/UBE2N, affecting control over a range of K63-Ub ligase proteins, including TRAF6, TRIM25, and RNF125, all of which are inactivated by LGP2. These findings establish a unifying mechanism for LGP2-mediated negative regulation that can modulate a variety of K63-Ub signaling pathways.
Original language | English (US) |
---|---|
Article number | 110175 |
Journal | Cell reports |
Volume | 37 |
Issue number | 13 |
DOIs | |
State | Published - Dec 28 2021 |
Funding
We are grateful to members of the Horvath lab for their guidance and helpful comments on this work and the manuscript, and Mehul Suthar (Emory) for helpful discussions. Supported by NIH grants R21AI148949 and R01GM111652 to C.M.H. J.J.L. was supported by Cellular and Molecular Basis of Disease Training grant (NIH T32 GM008061 ).
Keywords
- DHX58
- IFN
- K63-Ub
- LGP2
- RNF125
- TRAF6
- TRIM25
- UBE2N
- Ubc13
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology